Company Pipelines

• MolgramostimMolbreevi / GM-CSF receptor / Recombinant protein (rhGM-CSF) / Respiratory / Rare Lung Diseases
  Autoimmune Pulmonary Alveolar Proteinosis (aPAP)SubmissionRegulatory SubmissionUSUKEU

• TERN-701TERN-701 / BCR::ABL1 / Small Molecule / Oncology
  Chronic Myeloid Leukemia (CML)Phase 1/2ActiveGlobal

• pacibekitugTOUR006 / IL-6 / Monoclonal Antibody / Cardiovascular and Immune Diseases
  Atherosclerotic Cardiovascular Disease (ASCVD)Phase 2ActiveGlobalThyroid Eye Disease (TED)Phase 2ActiveGlobalAbdominal Aortic Aneurysm (AAA)Phase 2PlannedGlobal

• TSHA-102

• idecabtagene vicleucelAbecma / BCMA / CAR-T Cell Therapy / Oncology
  Relapsed or refractory multiple myelomaMarketedApprovedUSEU

• verekitugUPB-101 / TSLP receptor (TSLPR) / Monoclonal antibody / Respiratory/Inflammatory Diseases
  Severe AsthmaChronic rhinosinusitis with nasal polyps (CRSwNP)Chronic obstructive pulmonary disease (COPD)

• TelitaciceptRC18 / Taiai / BAFF/APRIL (BLyS/APRIL) / Recombinant Fusion Protein / Autoimmune Diseases
  Generalized Myasthenia Gravis (gMG)Phase 3Active / Approved in ChinaGlobalChinaSystemic Lupus Erythematosus (SLE)Phase 3Active / Approved in ChinaGlobalChinaRheumatoid Arthritis (RA)Phase 3Active / Approved in ChinaGlobalChina

• CadisegliatinTTP399 / Liver-selective glucokinase / Small molecule / Endocrinology
  Type 1 Diabetes (adjunctive to insulin)Phase 3OngoingUnited StatesType 2 DiabetesPhase 2PlannedUnited Arab Emirates

• AzenosertibZN-c3 / WEE1 / Small Molecule / Oncology
  Cyclin E1-positive platinum-resistant ovarian cancer (PROC)Advanced solid tumors

No disclosed assets in this row.